StockData
Abivax S.A. logo

Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$83.83+1.73 (+2.11%)

Close on Nov 18, 2026Market cap $6.58BP/E –Yield –

Abivax shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Abivax's shares outstanding was 80M at Jun 30, 2026. For fiscal 2025 it was 70M, up 10.3% from the year before. The highest annual figure on record is 70M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202570M+10.3%
FY2024Dec 31, 202463M+46.4%
FY2023Dec 31, 202343M+125.6%
FY2022Dec 31, 202219M+23.5%
FY2021Dec 31, 202115M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202680M+25.5%
Q1 FY2026Mar 31, 202679M+24.6%
Q4 FY2025Dec 31, 202578M+23.9%
Q3 FY2025Sep 30, 202573M+15.4%
Q2 FY2025Jun 30, 202563M+0.8%
Q1 FY2025Mar 31, 202563M+0.7%
Q4 FY2024Dec 31, 202463M–
Q3 FY2024Sep 30, 202463M–
Q2 FY2024Jun 30, 202463M–
Q1 FY2024Mar 31, 202463M–

More Abivax figures

See a number that looks wrong?